BioMarin Announces Record Breaking First Quarter 2023 Result

Growth of VOXZOGO® Accelerated with Rapid Uptake in Japan and Brazil Resulting in Increased Full-year 2023 GuidanceFull-year 2023 Top-line and Bot...

Related Keywords

France , Germany , Brazil , Italy , Canada , Japan , United States , German , Traci Mccarty , Jean Jacques Bienaim , Marni Kottle , National Association Of Statuary Health Insurance Funds , International Number , Company As , Company Annual , Biomarin Genzyme , Prnewswire Biomarin Pharmaceutical Inc , European Commission , Exchange Commission , Drug Administration , Biomarin Pharmaceutical Inc , Replay International Number , Nasdaq , Development Expense , Development Portfolio , Rapid Uptake , Brazil Resulting , Increased Full Year , Bottom Line Financial Guidance Reaffirmed , Net Product Revenue Guidance Adjusted , Growing Pipeline , Severe Hemophilia , Getting Tested , Preparations Underway Ahead , Drug User Fee Act , Target Action , Months Ended March , Product Revenues , Rare Pediatric Disease Priority Review Voucher , Marin Pharmaceutical , Chief Executive Officer , Outcomes Based Agreements , Total Revenues , Product Approvals , National Association , Statuary Health Insurance Funds , Named Patient , Biologics License Application , Major Amendment , Product Life Cycle Expansion Opportunities , New York City , Hereditary Angioedema , Duchenne Muscular Dystrophy , Investigational New Drug , Year Financial Guidance , Canada Dial In Number , Dial In Number , International Dial In Number , Biomarin Pharmaceutical , Net Product Revenues , Enzyme Product Revenues , Gross Profit , Administrative Expense , Annual Report , Nonqualified Deferred Compensation Plan , Consolidated Financial Statements , Net Income , Average Dilutive Shares Outstanding , Year Ended December ,